Table 2.
Reason for discontinuation | Number | % |
---|---|---|
Self discontinuation | 48 | 44.4 |
Provider recommendation- reached therapeutic endpoint | 25 | 23.1 |
Provider recommendation- suboptimal clinical response | 11 | 10.2 |
Adverse events: | 8 | 7.4 |
Lactic acidosis | 2 | |
GI, dermatologic, miscellaneous | 6 | |
Pregnancy related | 6 | 5.6 |
Miscellaneous- lost to follow up | 6 | 5.6 |
Suspected ETV resistance | 4 | 3.7 |
Total | 108 |